Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_1
1
20%
Ph phase_2
2
40%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 22 (40.0%)
N/A2 (40.0%)

Trials by Status

completed360%
terminated120%
unknown120%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_1

Fecal Transplant in Recurrent Hepatic Encephalopathy

NCT02636647
unknownnot_applicable

Fecal Transplant for Alopecia Areata

NCT04833179
completednot_applicable

Cesarean Section and Intestinal Flora of the Newborn

NCT03568734
completedphase_2

Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis

NCT01545908
terminatedphase_2

Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin

NCT01226992

Clinical Trials (5)

Showing 5 of 5 trials
NCT02636647Phase 1

Fecal Transplant in Recurrent Hepatic Encephalopathy

Completed
NCT04833179Not Applicable

Fecal Transplant for Alopecia Areata

Unknown
NCT03568734Not Applicable

Cesarean Section and Intestinal Flora of the Newborn

Completed
NCT01545908Phase 2

Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis

Completed
NCT01226992Phase 2

Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin

Terminated

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5